共 21 条
[1]
A randomized, double-blind, placebo-controlled, dose-response study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars. Norholt SE,Sindet-Pedersen S,Bugge C,et al. Journal of Clinical Pharmacology . 1995
[2]
Intravenous administration of lornoxicam, a new NSAID, and pethidine for postoperative pain.A placebo-controlled pilot study. Rosenow DE,van Krieken F,Stolke D,et al. Clinical Drug Investigation . 1996
[3]
Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Olkkola KT,Brunetto AV,Mattila MJ. Clinical Pharmacokinetics . 1994
[4]
Pharmacologic management of cancer pain. Levy MH. Seminars in Oncology . 1994
[5]
A longterm study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis. Huskisson EC,Ghozlan R,Kurthen R,et al. British Journal of Rheumatology . 1996
[6]
An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment. Bevis PJR,Bird HA,Lapham G. British Journal of Rheumatology . 1996
[7]
Safety of meloxicam: a global analysis of clinical trials. Distel M,Mueller C,Bluhmki E,et al. British Journal of Rheumatology . 1996
[8]
Comparisonoftheonsetandintensityofactionofintramuscularmeloxicamandoralmeloxicaminpatientswithacutesci atica. AuvinetB,ZillerR,AppelboomT,etal. Clinical Therapeutics . 1995
[9]
Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium. Hosie J,Distel M,Bluhmki E. British Journal of Rheumatology . 1996
[10]
A six-month double-blind trial to compare the efficacy and safety of meloxicam 7. 5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis. Wojtulewski JA,Schattenkirchner M,Barcelo P,et al. British Journal of Rheumatology . 1996